Unibest
← Back to patent-cliff list

CAS 288-32-4

1H-imidazole1,3-Diaza-2,4-cyclopentadiene

Codes: PRET-008, (V)70353-1-a, (IX)70353-2-a, (II)70353-4-a, DIQU-003, MICO-003

Application context (from source-drug indications)

Mycobacterium tuberculosis infectionPretomanidMultidrug-resistant tuberculosisPretomanidPulmonary tuberculosisPretomanidExtensively drug-resistant tuberculosisPretomanidRenal impairmentPretomanidBacterial and fungal infectionBetamethasone/Clotrimazole/Gentamicin SulfateDry eye diseaseDiquafosol TetrasodiumDry eye syndromeDiquafosol TetrasodiumKeratoconjunctivitis siccaDiquafosol TetrasodiumTrichomoniasisMiconazole/Metronidazole/LidocaineCandidiasisMiconazole/Metronidazole/LidocaineVaginitisMiconazole/Metronidazole/LidocaineCandidiasisClotrimazoleVulvovaginal candidiasisClotrimazoleAspergillus infectionClotrimazoleOtitis externaClotrimazolePruritusClotrimazolePityriasis versicolorClotrimazoleDermatomycosisMiconazoleTineaMiconazolePityriasis versicolorMiconazoleCandidiasisMiconazoleOral candidiasisMiconazole

Source drugs (routes using this intermediate)

DrugTierExpiry
PretomanidTier C — Watch / trade-
Betamethasone/Clotrimazole/Gentamicin SulfateTier C — Watch / trade-
Diquafosol TetrasodiumTier C — Watch / trade-
Miconazole/Metronidazole/LidocaineTier C — Watch / trade-
ClotrimazoleTier C — Watch / trade-
MiconazoleTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Betamethasone/Clotrimazole/Gentamicin SulfateOptimised routesteps: 1total yield: /
(2-Chlorophenyl) diphenyl chloromethane→1,3-Diaza-2,4-cyclopentadiene
ClotrimazoleOptimised routesteps: 1total yield: /
(2-Chlorophenyl) diphenyl chloromethane→1,3-Diaza-2,4-cyclopentadiene

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.